Title
Pharmacokinetics (PK) and Tolerability of AVP-786 in Healthy Volunteers
A Phase 1, Single-center, Randomized, Double-blind, Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Doses of AVP-786 (Deuterated Dextromethorphan) in Healthy Volunteers
Phase
Phase 1Lead Sponsor
AvanirStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
HealthyIntervention/Treatment
deuterated dextromethorphan quinidine dextromethorphan ...Study Participants
48To assess the single- and multiple-dose pharmacokinetic (PK), safety and tolerability of AVP-786 in healthy volunteers.
Single dose (D1) followed by twice daily dosing for 7 days
Single dose (D1) followed by twice daily dosing for 7 days
Single dose (D1) followed by twice daily dosing for 7 days
Single dose (D1) followed by twice daily dosing for 7 days
Single dose (D1) followed by twice daily dosing for 7 days
Inclusion Criteria: Healthy adult males 18 - 45 years of age BMI 18 - 30 kg/m2 Exclusion Criteria: History or presence of significant disease History of substance and/or alcohol abuse within the past 3 years Use of tobacco-containing or nicotine-contining products within 6 months Use of any prescription of over-the-counter (OTC) medication within 14 days